Sphera Management Technology Funds’s Cellebrite CLBT Stock Holding History

Sphera Management Technology Funds’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.14M	Buy	154,950 +74,950	+94%	+$1.13M	1.2%	28
2025 Q4	$1.44M	Sell	80,000 -90,000	-53%	-$1.62M	0.49%	42
2025 Q3	$3.15M	Buy	170,000 +100,000	+143%	+$1.57M	0.99%	21
2025 Q2	$1.12M	Buy	+70,000	New	+$1.25M	0.56%	48
2025 Q1	–	Sell	-40,000	Closed	-$881K	–	67
2024 Q4	$881K	Buy	+40,000	New	+$770K	0.51%	45

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sphera Management Technology Funds's CLBT Position: Q1 2026 in Review

Sphera Management Technology Funds increased its Cellebrite (CLBT) stake by 94% in Q1 2026, buying an estimated $1.13M and bringing the position to 154,950 shares worth $2.14M. The position accounts for 1.2% of the portfolio, ranked #28.

Sphera Management Technology Funds first reported a position in CLBT in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.15M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

Sphera Management Technology Funds held 154,950 shares of Cellebrite worth $2.14M as of Q1 2026.
Sphera Management Technology Funds bought 74,950 Cellebrite shares in Q1 2026, an estimated $1.13M.
Cellebrite made up 1.2% of Sphera Management Technology Funds's portfolio in Q1 2026, its #28 holding.
Sphera Management Technology Funds first reported a position in Cellebrite in Q4 2024 and has held it in 5 quarters since.
Sphera Management Technology Funds's Cellebrite position peaked at $3.15M in Q3 2025.
220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Sphera Management Technology Funds's 13F filing for Q1 2026, filed 15 May 2026.